ADMA Biologics Inc (ADMA)
9.10
-0.06
(-0.66%)
USD |
NASDAQ |
May 15, 16:00
9.10
0.00 (0.00%)
After-Hours: 07:00
ADMA Biologics Net Income (Quarterly): 17.81M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 17.81M |
December 31, 2023 | -17.64M |
September 30, 2023 | 2.565M |
June 30, 2023 | -6.371M |
March 31, 2023 | -6.789M |
December 31, 2022 | -12.23M |
September 30, 2022 | -14.90M |
June 30, 2022 | -13.76M |
March 31, 2022 | -25.01M |
December 31, 2021 | -16.65M |
September 30, 2021 | -17.71M |
June 30, 2021 | -18.91M |
March 31, 2021 | -18.38M |
December 31, 2020 | -19.41M |
September 30, 2020 | -16.92M |
June 30, 2020 | -20.18M |
March 31, 2020 | -19.25M |
December 31, 2019 | -10.56M |
September 30, 2019 | -11.44M |
June 30, 2019 | -13.21M |
March 31, 2019 | -13.07M |
December 31, 2018 | -18.04M |
September 30, 2018 | -15.14M |
June 30, 2018 | -14.75M |
March 31, 2018 | -17.82M |
Date | Value |
---|---|
December 31, 2017 | -12.98M |
September 30, 2017 | -15.20M |
June 30, 2017 | -9.036M |
March 31, 2017 | -6.537M |
December 31, 2016 | -4.559M |
September 30, 2016 | -4.331M |
June 30, 2016 | -6.012M |
March 31, 2016 | -4.612M |
December 31, 2015 | -4.583M |
September 30, 2015 | -5.102M |
June 30, 2015 | -4.679M |
March 31, 2015 | -3.606M |
December 31, 2014 | -3.563M |
September 30, 2014 | -3.385M |
June 30, 2014 | -3.961M |
March 31, 2014 | -5.904M |
December 31, 2013 | -4.701M |
September 30, 2013 | -2.689M |
June 30, 2013 | -4.895M |
March 31, 2013 | -3.242M |
December 31, 2012 | -2.252M |
September 30, 2012 | -3.246M |
June 30, 2012 | -1.207M |
March 31, 2012 | -0.5973M |
December 31, 2011 | -0.0083M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-25.01M
Minimum
Mar 2022
17.81M
Maximum
Mar 2024
-12.95M
Average
-15.77M
Median
Net Income (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | -4.146M |
ANI Pharmaceuticals Inc | 18.21M |
Ligand Pharmaceuticals Inc | 86.14M |
Johnson & Johnson | 3.255B |
Puma Biotechnology Inc | -4.815M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 81.88M |
Total Expenses (Quarterly) | 60.05M |
EPS Diluted (Quarterly) | 0.08 |
Enterprise Value | 2.195B |
Gross Profit Margin (Quarterly) | 47.77% |
Profit Margin (Quarterly) | 21.75% |
Earnings Yield | -0.22% |
Operating Earnings Yield | 2.14% |
Normalized Earnings Yield | 1.053 |